Beyond the Percentages of PD-L1-Positive Tumor Cells: Induced Versus Constitutive PD-L1 Expression in Primary and Metastatic Head and Neck Squamous Cell Carcinoma-Reference-Cited by-同舟云学术

Beyond the Percentages of PD-L1-Positive Tumor Cells: Induced Versus Constitutive PD-L1 Expression in Primary and Metastatic Head and Neck Squamous Cell Carcinoma

Published:2017-09-25 Issue:2 Volume:12 Page:221-229
ISSN:1936-055X
Container-title:Head and Neck Pathology
language:en
Short-container-title:Head and Neck Pathol

Author:

Scognamiglio Theresa^ORCID,Chen Yao-Tseng

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Otorhinolaryngology,Pathology and Forensic Medicine

Link

http://link.springer.com/article/10.1007/s12105-017-0857-3/fulltext.html

Reference25 articles.

1. Okazaki T, Honjo T. PD-1 and PD-1 ligands: from discovery to clinical application. Int Immunol. 2007;19(7):813–24. doi: 10.1093/intimm/dxm057 .

2. Page DB, Postow MA, Callahan MK, Allison JP, Wolchok JD. Immune modulation in cancer with antibodies. Annu Rev Med. 2014;65:185–202. doi: 10.1146/annurev-med-092012-112807 .

3. Sharma P, Allison JP. The future of immune checkpoint therapy. Science. 2015;348(6230):56–61. doi: 10.1126/science.aaa8172 .

4. Yao S, Zhu Y, Chen L. Advances in targeting cell surface signalling molecules for immune modulation. Nat rev Drug Discov. 2013;12(2):130–46. doi: 10.1038/nrd3877 .

5. Brahmer J, Reckamp KL, Baas P, Crino L, Eberhardt WE, Poddubskaya E, et al. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N Engl J Med. 2015;373(2):123–35. doi: 10.1056/NEJMoa1504627 .

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of PDL-1 between primary and recurrent/metastatic head and neck squamous cell carcinoma: A bi-institutional retrospective concordance analysis (CONCORDL-1 study);Oral Oncology;2024-10

2. Standardized Digital Image Analysis of PD-L1 Expression in Head and Neck Squamous Cell Carcinoma Reveals Intra- and Inter-Sample Heterogeneity with Therapeutic Implications;Cancers;2024-05-31

3. PD-L1 Expression in Colorectal Carcinoma Correlates with the Immune Microenvironment;Journal of Gastrointestinal Cancer;2024-03-26

4. Programmed Cell Death Ligand 1 Immunoexpression in Head and Neck Squamous Cell Carcinoma: A Narrative Review of Considerations for the Histopathologist;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2024

5. Immunohistochemical study of Programmed Cell Death Ligand 1 (PDL1) expression by combined positive score using 22C3 clone in head and neck squamous cell carcinomas, its correlation with clinicopathological features and outcome;Journal of Oral and Maxillofacial Pathology;2024-01